Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck CancerDiane C. Ling, Dwight E. Heron, John A. Vargo et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 70
Adjuvant stereotactic body radiotherapy ± cetuximab following salvage surgery in previously irradiated head and neck cancerJohn A. Vargo, Dwight E. Heron, Steven A. Burton et al.|The Laryngoscope|2013Cited by 40
Patterns of Relapse After Salvage Autologous Stem Cell Transplant for Hodgkin's Lymphoma: Should Sites of Relapse Relative to Initially Involved Sites Be Used to Guide Indications for Peri-Transplant Radiation TherapyJoshua C. Farris, John A. Vargo, Kelly Ross et al.|Practical Radiation Oncology|2018Cited by 1